BioSphere Medical, Inc. Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Apr 24 Calls Today's Calls

Call Details BioSphere Medical, Inc. Earnings Conference Call (Q1 2008) Thu, Apr 24, 2008, 8:30 am Eastern Listen to the archived event audio About BioSphere Medical, Inc. (NasdaqGM:BSMD) BioSphere Medical, Inc. develops, manufactures, and markets products for medical procedures that use embolotherapy. The company focuses on the treatment of symptomatic uterine fibroids, which are noncancerous, or benign, hypervascular tumors growing within or on the wall of the uterus, using a procedure called uterine fibroid embolization. Its microsphere products include Embosphere Microspheres for the treatment of uterine fibroids, hypervascularized tumors, and other arteriovenous malformations; EmboGold Microspheres for Hypervascularized tumors (other than uterine fibroids) and arteriovenous malformations; HepaSphere Microspheres to treat primary and metastatic liver cancer; and QuadraSphere Microspheres for the treatment of Hypervascularized tumors and arteriovenous malformations. The company’s delivery system products include EmboCath Plus Infusion Microcatheter for the infusion of various diagnostic, embolic, and therapeutic agents and super-selective angiography within peripheral vasculature; Sequitor Steerable Guidewire for diagnostic and interventional procedures within peripheral vasculature; and Segway Guidewire for peripheral embolization procedures. In addition, it develops MR Microspheres and Resorbable Microspheres, which are in preclinical research stages to treat uterine fibroids, hypervascularized tumors, and other arteriovenous malformations. The company also sells barium delivery kits and other ancillary products in the European Union for use in gastrointestinal medical testing. BioSphere Medical, Inc. markets its embolotherapy and delivery systems products through direct sales force in the United States and France, as well as through distributors primarily in Europe, Asia, Canada, the Middle East, Africa, and South America. The company was founded in 1993 and is based in Rockland, Massachusetts. More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Msgs | Insider | Financials | Analyst Ratings